title: Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy.
abstract: Auto-antibody mediated astrocyte injury is implicated as a primary event in neuromyelitis optica (NMO) by biomarker, post-mortem and experimental studies that differentiate the condition from multiple sclerosis. We describe the clinical, radiological and neuropathological features of a severe cerebral attack in a natalizumab-treated patient with relapsing myelitis and serum aquaporin-4 antibodies. Our findings support autopsy evidence that abrupt astrocyte destruction precedes demyelination in NMO, and emphasize the importance of serological testing in patients with limited disease. Adherence to current NMO diagnostic criteria may delay treatment, or lead to inappropriate therapy with beta-interferon or natalizumab.
authors.affiliation: Brain and Mind Research Institute, University of Sydney, Sydney, Australia. mbarnett@mail.usyd.edu.au
authors.forename: M H
authors.initials: MH
authors.lastname: Barnett
authors.forename: J W
authors.initials: JW
authors.lastname: Prineas
authors.forename: M E
authors.initials: ME
authors.lastname: Buckland
authors.forename: J D E
authors.initials: JD
authors.lastname: Parratt
authors.forename: J D
authors.initials: JD
authors.lastname: Pollard
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D051401:Aquaporin 4 / Q000276:immunology; D001253:Astrocytes / Q000473:pathology*; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069442:Natalizumab; D009471:Neuromyelitis Optica / Q000097:blood* / Q000188:drug therapy / Q000473:pathology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D051401:Aquaporin 4; D001323:Autoantibodies; D001324:Autoantigens; D000069442:Natalizumab